Search Results 161-170 of 6034 for albumin

  1. Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations - Mayo Clinic

    - Albumin levels < 2.5 g/dl - Any of the following because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effects ...

  2. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

    Serum albumin ≥ 2.8 g/dL. Acceptable liver function: Bilirubin ≤ 1.5 times upper limit of normal (x ULN); if liver metastases are present, then ≤ 2 x ULN ...

  3. Amino acids (intravenous route) - Mayo Clinic

    Amino acids injection is used for nutritional support of newborn babies (including babies with low birth weight) and children requiring total parenteral ...

  4. Drugs and Supplements that Start with T - Mayo Clinic

    Technetium tc 99m albumin aggregated (intravenous route) · Technetium tc 99m carbon (inhalation route) · Technetium tc 99m disofenin (intravenous route).

  5. Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

    Calcium ≥ LLN (corrected for serum albumin, if albumin abnormal). Magnesium ≥ LLN. Sodium ≥ LLN. Phosphorus ≥ LLN. NOTE: Supplementation may be given ...

  6. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

    Serum albumin ≥ 3.0 g/dL;; Creatinine clearance ≥ 30 mL/min either calculated or directly measured via 24-hour urine collection;; Serum potassium ≥ 3.5 ...

  7. Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery - Mayo Clinic

    Serum bovine immunoglobulin supplementation may improve the quality of life of patients with gynecological cancer. Participation eligibility. Participant ...

  8. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

    Albumin ≥ 2 g/dL within 7 days prior to enrollment. Left ventricular ejection fraction (LVEF) ≥ 53% (or institutional normal; if the LVEF result is given ...

  9. Publications - Ming Yang, M.D. - Mayo Clinic

    99mTc-Macroaggregated Albumin SPECT/CT Perfusion Imaging of Omental Extrahepatic Vascularization. Clin Nucl Med. 2016 Jan; 41: (1)e56-e57. View PubMed ...

  10. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

    ... albumin > 3.5 g/dL] AND standard-risk CA AND normal LDH. Stage II: Not R-ISS stage I or III; Stage III: ISS stage III [beta2 macroglobulin > 5.5 mg/L] AND ...